채용
Job Overview
Provide technical and general accounting services in accordance with IQVIA Finance Standard Operating Procedures (SOPs), US Generally Accepted Accounting Principles (US GAAP), Sarbanes-Oxley rules and financial reporting requirements of the business unit (e.g. local GAAP).
Essential Functions
- Support month end process within deadlines and instructions.
- Take responsibility for processing of ad hoc transaction in Fixed Asset Register in People Soft & SAP as additions, disposal, and update of asset properties (tag number, cost center etc.)
- Book regular monthly journals and ad hoc adjustments as required
- Prepare or review accounts reconciliations on timely basis in accordance with Group internal control guidelines.
- Ensure that accounting records are thoroughly maintained in preparation for independent audits.
- Provide full audit support during annual financial audits
- Participate in automation projects or initiatives
- Ensure appropriate communication with all business partners and support business partners in financial decisions, if required.
- Maintain and improve technical accounting skills.
- Perform other duties as assigned.
Qualifications
- High School Diploma or equivalent Req Or
- Bachelor's Degree Req
- 3 years’ experience Req Or
- Equivalent combination of education, training and experience Req
- Knowledge of Peoplesoft Finance or SAP modules.
- Knowledge of Microsoft Office applications.
- Technical accounting skills.
- Data analysis and manipulation skills.
- Ability to exercise judgment within procedures and practices to determine appropriate action.
- Ability to prioritize and coordinate multiple work requirements to meet deadlines.
- Ability to establish and maintain effective working relationships with co-workers, managers and clients.
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com
IQVIA is committed to integrity in our hiring process and maintains a zero tolerance policy for candidate fraud. All information and credentials submitted in your application must be truthful and complete. Any false statements, misrepresentations, or material omissions during the recruitment process will result in immediate disqualification of your application, or termination of employment if discovered later, in accordance with applicable law. We appreciate your honesty and professionalism.
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고

Bankruptcy Analyst, Global Credit Risk & Bankruptcy Team
Amazon · Bratislava, SVK

Finance Graduate Program - Future (2026) and Fresh (2025) Graduates
Dell · Bratislava, Slovakia

Financial Controller
IKEA · Bratislava, Bratislavský Kraj, Slovakia

Financial Reporting, Analyst
BlackRock · Mumbai, India

AR Analyst with German (B2B), Finance Analyst
Amazon · Bratislava, SVK
IQVIA 소개

IQVIA
PublicIQVIA Holdings, Inc. is an American company based in Durham, North Carolina, focused on health information technology and clinical research.
10,001+
직원 수
Durham
본사 위치
$17B
기업 가치
리뷰
3.6
10개 리뷰
워라밸
3.8
보상
2.5
문화
4.0
커리어
3.2
경영진
2.8
65%
친구에게 추천
장점
Good work-life balance
Supportive team and collaborative environment
Good benefits and flexible hours
단점
Compensation below industry standards
High workload and overwhelming at times
Management communication and organization issues
연봉 정보
45개 데이터
Mid/L4
Mid/L4 · ANALYST
2개 리포트
$97,500
총 연봉
기본급
$102,667
주식
-
보너스
-
$97,500
$97,500
면접 경험
3개 면접
난이도
3.0
/ 5
소요 기간
14-28주
경험
긍정 0%
보통 33%
부정 67%
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Technical Manager Interview
5
Executive/GM Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Case Study
Technical Knowledge
Past Experience
Culture Fit
뉴스 & 버즈
IQVIA Shareholders Approve New 2026 Incentive Plan - TipRanks
TipRanks
News
·
1d ago
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
MarketWatch
News
·
1d ago
The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares - Fierce Pharma
Fierce Pharma
News
·
1d ago
The outlook for obesity from 2026 to 2030 - IQVIA
IQVIA
News
·
3d ago